| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 13 Aug 24 | EXEL Exelixis | Common Stock | Other | Dispose J | No | No | 0 | 4,682 | 0.00 | 10,778 |
| 5 Jun 24 | STOK Stoke Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 16.41 | 7,639 | 125.36 k | 7,639 |
| 31 May 24 | EXEL Exelixis | Common Stock | Grant | Acquire A | No | No | 0 | 10,015 | 0.00 | 15,460 |
| 31 May 24 | EXEL Exelixis | Option Common Stock | Grant | Acquire A | No | No | 21.69 | 20,030 | 434.45 k | 20,030 |
| 21 May 24 | EXEL Exelixis | Common Stock | Sell | Dispose S | No | No | 21.12 | 27,280 | 576.15 k | 5,445 |
